Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial

Paul Sargos, Sylvie Chabaud, Igor Latorzeff, Nicolas Magné, Ahmed Benyoucef, Stéphane Supiot, David Pasquier, Menouar Samir Abdiche, Olivier Gilliot, Pierre Graff-Cailleaud, Marlon Silva, Philippe Bergerot, Pierre Baumann, Yazid Belkacemi, David Azria, Meryem Brihoum, Michel Soulié, Pierre Richaud

Open source

DOI: 10.1016/s1470-2045(20)30454-x
Published: 2020-10
Container: The Lancet Oncology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s1470-2045-20-30454-x,
  title = {Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial},
  author = {Paul Sargos and Sylvie Chabaud and Igor Latorzeff and Nicolas Magné and Ahmed Benyoucef and Stéphane Supiot and David Pasquier and Menouar Samir Abdiche and Olivier Gilliot and Pierre Graff-Cailleaud and Marlon Silva and Philippe Bergerot and Pierre Baumann and Yazid Belkacemi and David Azria and Meryem Brihoum and Michel Soulié and Pierre Richaud},
  year = {2020},
  journal = {The Lancet Oncology},
  doi = {10.1016/s1470-2045(20)30454-x},
  url = {https://doi.org/10.1016/s1470-2045(20)30454-x}
}

RIS

TY  - JOUR
TI  - Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial
AU  - Paul Sargos
AU  - Sylvie Chabaud
AU  - Igor Latorzeff
AU  - Nicolas Magné
AU  - Ahmed Benyoucef
AU  - Stéphane Supiot
AU  - David Pasquier
AU  - Menouar Samir Abdiche
AU  - Olivier Gilliot
AU  - Pierre Graff-Cailleaud
AU  - Marlon Silva
AU  - Philippe Bergerot
AU  - Pierre Baumann
AU  - Yazid Belkacemi
AU  - David Azria
AU  - Meryem Brihoum
AU  - Michel Soulié
AU  - Pierre Richaud
PY  - 2020
JO  - The Lancet Oncology
DO  - 10.1016/s1470-2045(20)30454-x
UR  - https://doi.org/10.1016/s1470-2045(20)30454-x
ER  -

APA

Sargos, P., Chabaud, S., Latorzeff, I., Magné, N., Benyoucef, A., Supiot, S., Pasquier, D., Abdiche, M. S., Gilliot, O., Graff-Cailleaud, P., Silva, M., Bergerot, P., Baumann, P., Belkacemi, Y., Azria, D., Brihoum, M., Soulié, M., & Richaud, P. (2020). Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(20)30454-x

Source records

crossref · retrieved 2026-11-04T13:15:02.917Z